Physician Optimised Post-partum Hypertension Treatment Trial

NAActive, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

February 21, 2020

Primary Completion Date

April 1, 2022

Study Completion Date

December 1, 2030

Conditions
Pre-EclampsiaGestational Hypertension
Interventions
DEVICE

OMRON Evolv® blood pressure monitor (Blue-tooth® enabled) & Proprietary Smartphone POP-HT app®

The intervention will consist of physician-optimised self-management of post-partum BP. Women will follow a 'smartphone' app based algorithm for medication-titration, which will provide individualised dose titration advice. This is overseen and any change is approved by physicians who can review the uploaded readings and respond to tele-monitored abnormal readings in a timely fashion.

Trial Locations (2)

OX3 9DU

Oxford University Hospitals NHS Foundation Trust, Oxford

Cardiovascular Clinical Research Facility, Dept of Cardiovascular Medicine, University of Oxford, Oxford

All Listed Sponsors
collaborator

British Heart Foundation

OTHER

lead

University of Oxford

OTHER